About InNeuroCo
InNeuroCo is a company based in Sunrise (United States) founded in 2014 by Marc Litzenberg and Daniel Sablyak was acquired by Integer in October 2023. InNeuroCo has raised $1.51 million across 3 funding rounds from investors including Integer. The company has 99 employees as of December 31, 2022. InNeuroCo offers products and services including Catheter Solutions and Medical Devices. InNeuroCo operates in a competitive market with competitors including Huake Precision (Beijing) Medical Technology, Q’Apel Medical, Zeta Surgical, ClaroNav and Impulse Monitoring, among others.
- Headquarter Sunrise, United States
- Employees 99 as on 31 Dec, 2022
- Founders Marc Litzenberg, Daniel Sablyak
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inneuroco, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InNeuroCo
InNeuroCo offers a comprehensive portfolio of products and services, including Catheter Solutions and Medical Devices.
Develops innovative catheters for brain aneurysm treatments.
Creates life-saving tools for neurovascular procedures.
People of InNeuroCo
Unlock access to complete
Product Management Team
3 people
QC Team
1 people
Operations Team
1 people
Principal Team
1 people
Document Team
1 people
Unlock access to complete
Funding Insights of InNeuroCo
InNeuroCo has successfully raised a total of $1.51M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $800.01 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InNeuroCo
InNeuroCo has secured backing from 1 investor. Prominent investors backing the company include Integer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical device components are developed and manufactured for healthcare markets.
|
Locked | Locked | Locked |
Investor details for InNeuroCo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InNeuroCo
Investment portfolio details for InNeuroCo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InNeuroCo
Detailed financials for InNeuroCo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inneuroco Comparisons
Peer comparison for InNeuroCo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InNeuroCo
InNeuroCo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Huake Precision (Beijing) Medical Technology, Q’Apel Medical, Zeta Surgical, ClaroNav and Impulse Monitoring, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| Locked | Locked | Locked |
Medical devices for neurovascular disorder treatments are provided.
|
|
| Locked | Locked | Locked |
AI-based navigation and robotics systems for surgeries are developed.
|
|
| Locked | Locked | Locked |
Medical 3D visualization and surgical navigation solutions are developed.
|
|
| Locked | Locked | Locked |
Intraoperative neurophysiological monitoring is conducted for spinal and brain surgeries.
|
Detailed competitors of InNeuroCo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inneuroco
Complete news archive for InNeuroCo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InNeuroCo
InNeuroCo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
InNeuroCo is headquartered in Sunrise, United States. It is registered at Sunrise, Florida, United States.
Marc Litzenberg is the current CEO of InNeuroCo. They have also founded this company.
InNeuroCo is a funded company, having raised a total of $1.51M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at InNeuroCo is 99.
InNeuroCo is a developer of devices for neurovascular surgeries. The companys Super Distal Access (SDA) is FDA 510(k) cleared (K161262) and it is indicated for the introduction of interventional devices into the peripheral and neuro vasculature. The companys Long Sheath also received FDA 510(k) clearance (K152876) and is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature. The company has partnered with Codman Neuro for the distribution of its intermediate catheter range.
InNeuroCo's top competitors include Huake Precision (Beijing) Medical Technology, Zeta Surgical and Q’Apel Medical.
InNeuroCo offers Catheter Solutions and Medical Devices.
InNeuroCo has 1 investor. Key investors include Integer.